100 episodes

On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.

Life Science Success Don Davis PhD, MBA

    • Science
    • 5.0 • 8 Ratings

On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.

    Bill Enright: 30 Years of Biotech Innovation in Life Sciences

    Bill Enright: 30 Years of Biotech Innovation in Life Sciences

    In this episode of Life Science Success, host Don Davis interviews Bill Enright, a seasoned biotech executive with over 30 years of experience.
     
    They discuss Bill's career journey from pre-med student to CEO roles, his experiences with companies like Barinthus Bio, Altimmune, GenVec, and Life Technologies, and his strategic insights on leading biotech firms. Bill shares valuable leadership lessons, the importance of corporate culture, and the role of innovation in advancing precision immunotherapies.
     
    He also highlights his board position at Bullfrog AI and how AI is transforming the life sciences landscape. Tune in to learn about Bill's inspiring path and the future of biotech.
     
     
    00:00 Introduction to Life Science Success Podcast
    00:41 Sponsor Message: D3 Digital Media Marketing
    01:28 Guest Introduction: Bill Enright
    01:49 Bill Enright's Career Journey
    09:38 Challenges and Resilience in Biotech
    14:38 Board Membership and AI in Life Sciences
    18:04 Barinthus Bio: Mission and Projects
    25:54 Leadership and Corporate Culture
    34:28 Closing Remarks and Podcast Information

     

    • 35 min
    Innovative Precision Medicine: Ayla Annac's Journey at InvivoSciences

    Innovative Precision Medicine: Ayla Annac's Journey at InvivoSciences

    Introduction of InvivoSciences: Ayla Annac, co-founder and CEO of InvivoSciences, discusses the company's focus on developing therapies for cardiovascular and cardiometabolic diseases through innovative precision medicine technology.
    Personal Motivation: Ayla’s passion for addressing cardiovascular diseases stems from the personal loss of her father to heart disease at a young age, which motivated her to pursue solutions in this medical field.
    Technological Innovation: InvivoSciences utilizes a proprietary platform named Cordia for drug discovery and to identify subpopulations that match specific drugs, enhancing the effectiveness and safety of medications.
    Challenges and Perseverance: Ayla highlights the financial and industry challenges in drug development, emphasizing the need for increased investment and collaboration within the sector to bring innovative treatments to market.
    Vision and Future Goals: Ayla's mission extends beyond her company to push for a broader adoption of precision medicine in cardiovascular treatment, aiming to develop effective drugs that can significantly reduce the impact of heart diseases globally.

     
    00:00 Introduction to Life Science Success Podcast
    00:48 Sponsor Message: D3 Digital Media Marketing
    01:30 Guest Introduction: Ayla Anak, CEO of InvivoSciences
    02:10 Ayla's Personal Journey and Motivation
    07:43 Challenges and Innovations in Cardiovascular Drug Development
    08:59 The Journey of InvivoSciences
    14:06 The Importance of Precision Medicine
    24:54 Overcoming Challenges and Building a Team
    34:39 Leadership Advice and Personal Inspirations
    42:25 Conclusion and Final Thoughts

    • 43 min
    Revolutionizing Biotech: Markus Gershater on AI-Powered Labs & Synthace

    Revolutionizing Biotech: Markus Gershater on AI-Powered Labs & Synthace

    In this episode of the Life Science Success Podcast episode featuring Markus Gershater, co-founder of Synthace, listeners can learn about the intersection of synthetic biology, AI, and automation in revolutionizing life sciences research and development. Here are the key points:
    Role of Synthetic Biology and AI in Life Sciences: Markus discusses how Synthace leverages synthetic biology and AI to automate and enhance laboratory experiments, focusing on improving the efficiency and effectiveness of research processes.
    Design of Experiments (DOE): The conversation highlights the application of DOE, a statistical method that allows simultaneous examination of multiple input factors to determine their effect on a desired output, which is critical in managing the complexity of biological systems.
    Impact of Automation in Research: Markus explains how automation integrated through Synthace can significantly speed up and increase the precision of biological experiments, reducing the time and cost associated with traditional methods.
    Challenges and Opportunities with New Technologies: The discussion also covers the challenges of adopting new technologies in traditional research settings, the potential of AI to transform discovery processes, and the importance of aligning innovations with actual lab workflows.
    Vision and Aspirations for the Future: Markus shares his optimistic view on the potential of advanced technologies to make substantial impacts on life sciences, expressing hope and excitement about future possibilities to understand and control biological complexity more effectively.
    This episode provides insights into how cutting-edge technologies are shaping the future of biotechnological research and emphasizes the importance of integrating new tools with current scientific practices to maximize their benefits.

    • 1 hr
    How William Hind's Belief Continuum is Revolutionizing Pharma Communication

    How William Hind's Belief Continuum is Revolutionizing Pharma Communication

    In this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers.
    In this episode of Life Science Success, host Don interviews William Hind, founder of Alpharmaxim, about the importance of effective communication in the life sciences industry.
     
    William shares his journey from working at MSD (Merck) to founding Alpharmaxim, emphasizing the need for storytelling and behavioral science in pharmaceutical communications. They discuss overcoming barriers in healthcare communication, the role of behavioral science, and the potential and challenges of AI in the pharmaceutical industry. Brought to you by D3 Digital Media Marketing, this episode delves deep into transforming pharma communication through scientific, validated methods.
     
    00:00 Introduction to Life Science Success Podcast
    00:39 Sponsor Message: D3 Digital Media Marketing
    01:22 Guest Introduction: William Hind of Alpharmaxim
    01:51 William Hind's Career Journey
    05:47 Founding Alpharmaxim
    07:12 The Importance of Storytelling in Pharma
    12:27 Behavioral Science in Healthcare Communication
    18:55 Challenges in Pharma Communication
    24:14 Staying Updated in the Industry
    34:25 Leadership and Personal Insights
    42:50 Conclusion and Farewell

    • 43 min
    Unlocking Precision Cancer Care with Tushar Pandey CEO SymBioSys

    Unlocking Precision Cancer Care with Tushar Pandey CEO SymBioSys

    Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and improving patient outcomes.
     
    In this episode of the Life Science Success Podcast, host Don interviews Tushar Pandey, CEO and Co-founder of SymBioSys, an innovative company reshaping precision cancer care. Tushar shares his intriguing journey from Uganda to the United States, his transition from engineering to healthcare, and the personal experiences that sparked his passion for precision medicine. The discussion highlights SymBioSys’ groundbreaking work in creating digital, cost-effective diagnostics to reduce uncertainty in cancer treatment. They explore the importance of addressing diversity in medical models, harnessing the power of AI, and solving challenges in drug development and patient care. Agendas like the company's comprehensive platform for early-stage breast cancer get a deep dive, showcasing how they bridge imaging, genomics, and patient-centered care for improved outcomes. This conversation is a rich mix of personal narrative, professional insights, and forward-thinking solutions in life sciences.
     
     
    00:00 Introduction to Life Science Success Podcast
    00:34 Sponsor Message from D3 Digital Media Marketing
    01:25 Guest Introduction: Tushar Pandey
    02:27 Tushar's Background and Journey
    04:30 Early Career and Transition to Healthcare
    06:01 Strata Decision Technology and Cost Optimization
    07:57 Personal Impact of Cancer and Shift to Precision Medicine
    08:54 Founding Symbiosis and Mission
    11:04 Challenges and Innovations in Cancer Treatment
    12:21 Symbiosis' Approach to Precision Medicine
    14:04 Scientific and Emotional Theses
    15:34 Digital Solutions and Global Scale
    15:58 Breast Cancer Treatment and FDA Approval
    18:05 Supporting Drug Developers and Dosing Regimens
    19:30 Digital Orientation and Multi-Omics Data
    20:24 Identifying Critical Data in Precision Medicine
    20:50 Incorporating Diversity in Medical Models
    23:49 Innovative Projects in Digital Health
    25:07 The Role of Imaging in Precision Medicine
    31:08 Challenges in Life Sciences and Overcoming Them
    33:31 Leadership and Inspiration in Precision Medicine
    37:28 Concerns and Future Directions in Healthcare
    42:02 Conclusion and Final Thoughts

     

    • 42 min
    Stephanie Oestreich: Advancing Myeloma Research & Investment

    Stephanie Oestreich: Advancing Myeloma Research & Investment

    In this episode of the Life Science Success Podcast we are joined by Stephanie Oestreich, Managing Director of the Myeloma Investment Fund, who has an extensive background in life sciences, leadership, and a unique perspective as a semi-professional violinist.
     
    Stephanie shares her extensive background in life sciences and leadership, and discusses her passion for finding cures and treatments for devastating diseases like multiple myeloma. She provides insight into the innovative work of the Myeloma Investment Fund, their mission, and the process of fostering and investing in breakthrough therapies. Stephanie also touches on her teaching role at MIT and her unique perspective as a semi-professional violinist, drawing parallels between her musical and professional experiences.
     
    00:00 Introduction to the Podcast
    00:32 Sponsor Message: D3 Digital Media Marketing
    01:21 Meet Stephanie Asterik
    01:54 Stephanie's Journey in Life Sciences
    03:48 The Complexity of Multiple Myeloma
    04:51 Investing in Innovation
    08:42 The Role of the Myeloma Investment Fund
    11:03 Stephanie's Background and Leadership Lessons
    15:02 The Art of Playing the Violin
    18:33 Leadership Insights from Music
    22:07 Final Thoughts and Reflections
    27:55 Conclusion and Farewell

     

    • 28 min

Customer Reviews

5.0 out of 5
8 Ratings

8 Ratings

Top Podcasts In Science

Hidden Brain
Hidden Brain, Shankar Vedantam
Radiolab
WNYC Studios
Short Wave
NPR
Ologies with Alie Ward
Alie Ward
Making Sense with Sam Harris
Sam Harris
StarTalk Radio
Neil deGrasse Tyson

You Might Also Like